Atea Pharmaceuticals, Inc.AVIRNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank14
Studio
Year-over-Year Change

Return on equity

Latest
-57.49%
↓ 175% vs avg
Percentile
P14
Within normal range
Streak
4 yr
Consecutive declineContracting
Average
-20.90%
Historical baseline
PeriodValueYoY Change
2025-57.49%-49.8%
2024-38.37%-56.7%
2023-24.49%-35.3%
2022-18.09%-206.0%
202117.07%+954.1%
2020-2.00%+97.1%
2019-68.87%-374.8%
201825.07%-